We previously compared outcomes after allogeneicperipheral-bloodstemcell (PBSC) and bone marrow (BM) transplantation in 706 patients with leukemia. We obtained long-term follow up on 413 of 491 patients who were alive at the time of the initial report: 141 PBSC and 272 BM recipients. Chronic graft-versus-host disease (GVHD) was more frequent after PBSC compared to BM transplantation (RR 1.65, P<.001) yet relapse rates were similar in both groups. Leukemia-free survival rates were higher after PBSC than BM transplantation for pa-tients with advanced chronic myeloid leuke-mia (33 % versus 25%) but lower for those in first chronic phase (41 % versus 61%) due to higher rates of late transplant-related mortal-ity. Leukemia-free survival was s...
AbstractPeripheral blood hematopoietic stem cell (PBSC) transplants have been shown to result in mor...
Increasing numbers of patients are receiving reduced intensity conditioning regimen allogeneic hemat...
Increasing numbers of patients are receiving reduced-intensity-conditioning regimen allogeneic hemat...
AbstractWe sought to determine whether differences in chronic graft-versus-host disease (GVHD) rates...
Information on the outcome of allogeneic bone marrow transplant (BMT) for chronic myeloid leukaemia ...
Peripheral blood (PB) and bone marrow (BM) from unrelated donors can serve as a graft source for hem...
AbstractSeventy-two chronic myeloid leukemia patients were enrolled as part of a larger randomized t...
International audienceSince cord blood transplantation (CBT) has been associated with high graft-ver...
Objective: To determine long-term health benefits of nonablative bone marrow transplantation for sev...
Item does not contain fulltextOut of 690 allogeneic matched sibling donor transplants for multiple m...
We report the results of a retrospective single-center study comparing engraftment, acute and chroni...
Contains fulltext : 170901.pdf (publisher's version ) (Open Access)BACKGROUND: Mye...
years with a median age of 29, underwent hematopoietic stem cell transplantation. Eighty-eight patie...
Contains fulltext : 24325___.PDF (publisher's version ) (Open Access
AbstractPeripheral blood hematopoietic stem cell (PBSC) transplants have been shown to result in mor...
Increasing numbers of patients are receiving reduced intensity conditioning regimen allogeneic hemat...
Increasing numbers of patients are receiving reduced-intensity-conditioning regimen allogeneic hemat...
AbstractWe sought to determine whether differences in chronic graft-versus-host disease (GVHD) rates...
Information on the outcome of allogeneic bone marrow transplant (BMT) for chronic myeloid leukaemia ...
Peripheral blood (PB) and bone marrow (BM) from unrelated donors can serve as a graft source for hem...
AbstractSeventy-two chronic myeloid leukemia patients were enrolled as part of a larger randomized t...
International audienceSince cord blood transplantation (CBT) has been associated with high graft-ver...
Objective: To determine long-term health benefits of nonablative bone marrow transplantation for sev...
Item does not contain fulltextOut of 690 allogeneic matched sibling donor transplants for multiple m...
We report the results of a retrospective single-center study comparing engraftment, acute and chroni...
Contains fulltext : 170901.pdf (publisher's version ) (Open Access)BACKGROUND: Mye...
years with a median age of 29, underwent hematopoietic stem cell transplantation. Eighty-eight patie...
Contains fulltext : 24325___.PDF (publisher's version ) (Open Access
AbstractPeripheral blood hematopoietic stem cell (PBSC) transplants have been shown to result in mor...
Increasing numbers of patients are receiving reduced intensity conditioning regimen allogeneic hemat...
Increasing numbers of patients are receiving reduced-intensity-conditioning regimen allogeneic hemat...